PAPER
Enantioselective Synthesis of N-Protected a-Amino Acid Hydrazides
1183
(C2C6 Phe), 127.6 (C4 Cbz), 128.1–128.2–129.2 (C2C3C5C6 Cbz,
Phe), 129.5 (C8C9 Phth), 135.2 (C5C6 Phth), 136.9 (C1 Cbz), 137.5
(C1 Phe), 155.8 (CO Cbz), 164.9 (C1C3 Phth), 171.2 (CO hy-
drazide).
13C NMR (75 MHz, DMSO-d6): d = 10.7 (Cd Ile), 15.1 (CH3g Ile),
24.3 (CH2g Ile), 36.5 (CHb Ile), 46.6 (CH Fmoc), 57.3 (CHa Ile),
65.8 (CH2 Fmoc), 120.0 (C1C8 Fmoc), 123.7 (C4C7 Phth), 125.4
(C2C7 Fmoc), 127.0 (C4C5 Fmoc), 127.6 (C3C6 Fmoc), 129.4 (C8C9
Phth), 135.2 (C5C6 Phth), 140.7, 143.6, 143.9 (C4a/b, C8a/b Fmoc),
156.0 (CO Fmoc), 165.0 (C1C3 Phth), 170.0 (CO hydrazide).
Fmoc(L)-Phenylalanine-phthalimide (2b)
1H NMR (300 MHz, DMSO-d6): d = 2.93 (dd, J = 11, 13 Hz, 1 H,
CH2b Phe), 3.19 (dd, 1 H, 3, 14 Hz, CH2b Phe), 4.17 (m, 3 H,
CH2CH Fmoc), 4.56 (m, 1 H, CHa Phe), 7.19–7.34 (m, 6 H,
H2H3H4H5H6 Phe, NH Fmoc), 7.40 (m, 4 H, H3H6H2H7 Fmoc), 7.65
(m, 2 H, H4H5 Fmoc), 7.88 (d, J = 7 Hz, 2 H, H1H8 Fmoc), 7.97 (m,
4 H, H4H5H6H7 Phth), 11.00 (s, 1 H, NH hydrazide).
Compounds 4a–l; General Procedure
Aminomethylated polystyrene resin (3 equiv; 1.1 mmol/g, 100–200
mesh) was conditioned for 10 min at r.t. in CH2Cl2. Then 2 (1 equiv)
was added, and the mixture was slowly stirred for 24 h at r.t. The
mixture was filtered and the solvent was evaporated in vacuo to give
product 4 as a white solid.
13C NMR (75 MHz, DMSO-d6): d = 38.9 (CH2b Phe), 46.5 (CHCH2
Fmoc), 54.6 (CHa Phe), 65.8 (CHCH2 Fmoc), 120.0 (C1C8 Fmoc),
123.7 (C4C7 Phth), 125.3 (C2C7 Fmoc), 126.4 (C4 Phe), 127.0 (C4C5
Fmoc), 127.6 (C3C6 Fmoc), 128.1, 129.2 (C2C3C5C6 Phe), 129.5
Fmoc(L)-Phenylalanine-NHNH2 (4a)
1H NMR (300 MHz, DMSO-d6): d = 2.85 (dd, J = 10 Hz, 1 H, CH2b
Phe), 2.93 (dd, J = 13 Hz, 1 H, CH2b Phe), 4.20 (m, 6 H, CH2CH
Fmoc, NHNH2, CHa Phe), 7.20 (d, J = 6 Hz, 1 H, NH Fmoc), 7.24–
7.35 (m, 7 H, H2H3H4H5H6 Phe, H2H7 Fmoc), 7.41 (t, J = 7 Hz, 2 H,
H3H6 Fmoc), 7.64 (dd, J = 7, 12 Hz, 2 H, H4H5 Fmoc), 7.88 (d, J =
7 Hz, 2 H, H1H8 Fmoc), 9.21 (s, 1 H, NHNH2).
(C8C9 Phth), 135.2 (C5C6 Phth), 137.6 (C1 Phe), 140.6–143.6 (C4a/b
,
C8a/b Fmoc), 155.8 (CO Fmoc), 164.9 (C1C3 Phth), 171.2 (CO hy-
drazide).
Boc(L)-Tyrosine(DCB)-phthalimide (2c)
1H NMR (300 MHz, DMSO-d6): d = 1.31 (s, 9 H, CH3 Boc), 2.82
(dd, J = 9, 14 Hz, 1 H, CH2b Tyr), 3.09 (dd, J = 3, 14 Hz, 1 H, CH2b
Tyr), 4.42 (m, 1 H, CHa Tyr), 5.20 (s, 2 H, CH2 DCB), 6.98–7.10
(dd, J = 8, 9 Hz, 2 H, H3H5 Tyr, NH Boc), 7.34 (d, J = 8 Hz, 2 H,
H2H6 Tyr), 7.44–7.57 (m, 3 H, H3H4H5 DCB), 7.92–8.00 (m, 4 H,
H4H5H6H7 Phth), 10.85 (s, 1 H, NH hydrazide).
13C NMR (75 MHz, DMSO-d6): d =37.7 (CH2b Phe), 46.5 (CHCH2
Fmoc), 54.9 (CHa Phe), 65.6 (CHCH2 Fmoc), 120.0 (C3C6 Fmoc),
125.2, 125.3 (C2C7 Fmoc), 126.2 (C4 Phe), 127.0 (C4C5 Fmoc),
127.5 (C3C6 Fmoc), 128.0, 129.1 (C2C3C5C6 Phe), 138.0 (C1 Phe),
140.6, 143.7 (C4a/4b, C8a/8b Fmoc), 155.6 (CO Fmoc), 170.7 (CO hy-
drazide).
13C NMR (75 MHz, DMSO-d6): d = 28.1 (CH3 Boc), 36.8 (CH2b
Tyr), 54.4 (CHa Tyr), 64.8 (CH2 DCB), 78.2 (C quat Boc), 114.2
(C3C5 Tyr), 123.7 (C4C7 Phth), 128.7 (C3C5 DCB), 129.5 (C8C9
Phth), 130.2 (C1 Tyr), 130.3 (C2C6 Tyr), 131.4 (C4 DCB), 135.2
(C5C6 Phth), 136.0 (C1 DCB), 155.2 (CO Boc), 157.1 (C4 Tyr),
164.9 (C1C3 Phth), 171.3 (CO hydrazide).
Boc(L)-Tyrosine(DCB)-NHNH2 (4c)
1H NMR (300 MHz, DMSO-d6): d = 1.30 (s, 9 H, CH3 Boc), 2.65–
2.73 (dd, J = 10, 13 Hz, 1 H, CH2b Tyr), 2.81–2.87 (1 H, dd, J = 4,
14 Hz, CH2b Tyr), 4.08 (m, 1 H, CHa Tyr), 4.30 (sl, 2 H, NH2 hy-
drazide), 5.18 (s, 2 H, CH2 DCB), 6.83 (d, 1 H, 8 Hz, NH Boc), 6.95
(d, J = 8 Hz, 2 H, H3H5 Tyr), 7.19 (d, J = 8 Hz, 2 H, H2H6 Tyr), 7.43–
7.57 (m, 3 H, H3H4H5 DCB), 9.09 (s, 1 H, NH hydrazide).
Boc(L)-Tryptophan-phthalimide (2d)
1H NMR (300 MHz, DMSO-d6): d = 1.32 (s, 9 H, CH3 Boc), 3.03
(dd, J = 14, 10 Hz, 1 H, CH2 b Trp), 3.28 (m, 1 H, CH2 b Trp), 4.50
(m, 1 H, CHa Trp), 6.98 (t, J = 8 Hz, 1 H, H5 Trp), 7.02 (d, J = 7 Hz,
1 H, H4 Trp), 7.08 (t, J = 7 Hz, 1 H, H6 Trp), 7.23 (s, 1 H, H2 Trp),
7.35 (d, J = 8 Hz, 1 H, H7 Trp), 7.68 (d, J = 8 Hz, 1 H, NH Boc),
7.97 (m, 4 H, H4 H5 H6 H7 Phth), 10.86 (m, 2 H, NH indole Trp, NH
hydrazide).
13C NMR (75 MHz, DMSO-d6): d = 28.1 (CH3 Boc), 37.0 (CH2b
Tyr), 54.6 (CHa Tyr), 64.8 (CH2 DCB), 77.8 (C quat Boc), 114.1
(C3C5 Tyr), 128.7 (C3C5 DCB), 130.2 (C1 Tyr), 130.6 (C2C6 Tyr),
131.4 (C4 DCB), 131.7 (C2C6 Tyr), 136.0 (C1 DCB), 155.0 (CO
Boc), 156.9 (C4 Tyr), 170.9 (CO hydrazide).
Boc(L)-Tryptophan-NHNH2 (4d)
1H NMR (300 MHz, DMSO-d6): d = 1.31 (s, 9 H, CH3 Boc), 2.89
(dd, J = 9, 14 Hz, 1 H, CH2b Trp), 3.02 (dd, J = 5, 14 Hz, 1 H, CH2
b Trp), 4.17 (dd, J = 8 Hz, 1 H, CHa Trp), 4.29 (s, 2 H, NH2 hy-
drazide), 6.72 (d, J = 8 Hz, 1 H, NHBoc), 6.97 (t, J = 8 Hz, 1 H, H5
Trp), 7.06 (t, J = 7 Hz, 1 H, H6 Trp), 7.13 (s, 1 H, H2 Trp), 7.32 (d,
J = 8 Hz, 1 H, H4 Trp), 7.59 (d, J = 8 Hz, 1 H, H7 Trp), 9.12 (s, 1 H,
NH hydrazide), 10,78 (s, 1 H, NH Trp).
13C NMR (75 MHz, DMSO-d6): d = 27.9 (CH2 b Trp), 28.1 (CH3
Boc), 53.5 (CH a Trp), 78.2 (C quat Boc), 109.6 (C3 Trp), 111.3 (C7
Trp), 118.2 (C4 Trp), 118.4 (C5 Trp), 120.8 (C6 Trp), 123.7 (C4C7
Phth), 123.9 (C2 Trp), 127.3 (C9 Trp), 129.5 (C8C9 Phth), 135.2
(C5C6 Phth), 136.0 (C8 Trp), 155.1 (CO Boc), 165.0 (C1C3 Phth),
171.6 (CO hydrazide).
Boc-Glycine-phthalimide (2h)
13C NMR (75 MHz, DMSO-d6): d = 28.7 (CH3 Boc), 39.2 (CH2b
Trp), 53.7 (CHa Trp), 77.8 (C quat Boc), 110.1 (C3 Trp), 111.2 (C7
Trp), 118.1 (C4 Trp), 118.4 (C5 Trp), 120.7 (C6 Trp), 127.3 (C9 Trp),
136.0 (C8 Trp), 155.0 (CO Boc), 171.3 (CO hydrazide).
1H NMR (300 MHz, DMSO-d6): d = 1.39 (s, 9 H, CH3 Boc), 3.83
(d, J = 6 Hz, 2 H, CH2a Gly), 7.13 (t, J = 6 Hz, 1 H, NH Boc), 7.95
(m, 4 H, H4H5H6H7 Phth), 10.65 (s, 1 H, NH hydrazide).
13C NMR (75 MHz, DMSO-d6): d = 27.8 (CH3 Boc), 41.5 (CH2 a
Gly), 78.2 (C quat Boc), 123.7 (C4C7 Phth), 129.4 (C8C9 Phth),
135.2 (C5C6 Phth), 155.7 (CO Boc), 165.0 (C1C3 Phth), 169.0 (CO
hydrazide).
Fmoc(L)-Aspartic Acid(t-Bu)-NHNH2 (4g)
1H NMR (300 MHz, DMSO-d6): d = 1.37 (s, 9 H, CH3 t-Bu), 2.64
(m, 2 H, CH2b Asp), 4.24 (m, 6 H, CH2CH Fmoc, NHNH2, CHa
Asp), 7.33 (s, 2 H, H2H7 Fmoc), 7.42 (s, 2 H, H3H6 Fmoc), 7.57 (d,
J = 7 Hz, 1 H, NH Fmoc), 7.71 (s, 2 H, H4H5 Fmoc), 7.89 (d, J = 6
Hz 2 H, H1H8 Fmoc), 9.11 (s, 1 H, NHNH2).
Fmoc(L)-Isoleucine-phthalimide (2k)
1H NMR (300 MHz, DMSO-d6): d = 0.88 (t, J = 7 Hz, 3 H, CH3d
Ile), 1.02 (d, J = 6 Hz, 3 H, CH3g Ile), 1.23, 1.56 (m, 2 H, CH2g Ile),
1.84 (m, 1 H, CHb Ile), 4.17–4.33 (m, 4 H, CHCH2 Fmoc, CHa Ile),
7.34 (m, 2 H, H3H6 Fmoc), 7.44 (m, 2 H, H2H7 Fmoc), 7.72 (d, J =
10 Hz, 1 H, NH Fmoc), 7.77 (m, 2 H, H4H5 Fmoc), 7.92 (m, 6 H,
H4H5H6H7 Phth, H1H8 Fmoc), 10.88 (s, 1 H, NH hydrazide).
13C NMR (75 MHz, DMSO-d6): d = 27.6 (CH3 t-Bu), 37.5 (CH2b
Asp), 46.6 (CHa Asp), 50.3 (CH Fmoc), 65.7 (CH2 Fmoc), 80.1 (C
quat Boc), 120.0 (C1C8 Fmoc), 125.2 (C2C7 Fmoc), 127.0 (C3C6
Fmoc), 127.6 (C4C5 Fmoc), 140.6 (C4a/b Fmoc), 143.7 (C8a/b Fmoc),
155.6 (CO Fmoc), 169.2, 169.6 (CO t-Bu, hydrazide).
Synthesis 2009, No. 7, 1180–1184 © Thieme Stuttgart · New York